FDA Says Some Osteoporosis Drugs Have Possible Fracture Risks
The Food and Drug Administration (FDA) issued a warning on Wednesday, Oct. 13, about a possible risk of two rare types of thigh fractures in people who take bisphosphonates, a class of osteoporosis drugs that includes Fosamax and Boniva. Bisphosphonates work by slowing the loss of bone cells that lead to osteoporosis. Many studies suggest…